Status:

COMPLETED

Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

Sanofi

Conditions:

Type 2 Diabetes

Hyperglycemia

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to determine if the early initiation of a long acting insulin (i.e. glargine) with supplemental doses of short acting regular (SSR) insulin in hospitalized patients with d...

Detailed Description

Hyperglycemia is one of the most frequently encountered complications of enteral nutrition therapy in the hospital setting. However, there is no standardized approach directed towards the identificati...

Eligibility Criteria

Inclusion

  • Type 2 Diabetes defined according to ADA criteria
  • Enteral nutrition therapy
  • Two blood glucose readings \> 130 mg/dl within 48-hrs prior to or within a 48-hour period during enteral nutrition therapy
  • Men and women age \>/= 18
  • Ability for patient or legally authorized representative to understand and sign an informed consent document

Exclusion

  • Subjects with conditions that are anticipated to have short term (i.e. \< 2 months survival) based on discussions with the treatment team and attending physician.
  • Subjects admitted to the CT ICU or any unit with pre-established protocols for glycemic management.
  • Subjects with known type 1 diabetes (who will absolutely require a long or intermediate acting insulin preparation).
  • Subjects with known type 2 diabetes who currently receive 30 units or more of an intermediate or long acting insulin.
  • Pregnancy

Key Trial Info

Start Date :

February 1 2005

Trial Type :

INTERVENTIONAL

End Date :

August 1 2006

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT00177398

Start Date

February 1 2005

End Date

August 1 2006

Last Update

December 19 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States, 15213

Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings | DecenTrialz